Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasar Caliskan

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|October 31, 2003
Major depression and psoriasis activation due to interferon-alpha in a patient with chronic myeloid leukemia; "overlooked and/or misdiagnosed adverse reaction in malignant disease"Sevgi Kalayoglu Besisik, Gönenc Kocabey, Yasar Caliskan
Current Opinion in Organ Transplantation|February 26, 2026
Genetic testing in living kidney donor candidatesYasar Caliskan, Laura Binari, Heidi M Schaefer
The International Journal of Artificial Organs|February 4, 2010
Outcomes of renal transplants from spousal donors: 25 years of experience at our centerNuman Gorgulu, Yasar Caliskan, Berna Yelken, et al.
Current Transplantation Reports|May 19, 2025
Complement-Mediated Kidney Disease and Living Donor Transplantation: Tailoring Approaches to Improve OutcomesAliza Anwar Memon, Krista L Lentine, Yasar Caliskan
Iranian Journal of Kidney Diseases|August 13, 2022
Silica Urinary Stones: A Case Report and A Brief Review of LiteratureYasar Caliskan, Jonathan Buck, Lindsay Lombardo, et al.
Transplantation|April 17, 2003
Cyclosporine-associated hyperkalemia: report of four allogeneic blood stem-cell transplant casesYasar Caliskan, Sevgi Kalayoglu-Besisik, Deniz Sargin, et al.
Seminars in Nephrology|July 22, 2025
Communicating Risk Alleles in Kidney Genes: Lessons from APOL1 and New Discoveries of Risk AllelesYasar Caliskan, Ana Iltis, Janewit Wongboonsin, et al.
Current Transplantation Reports|March 17, 2025
Use of Anti-interleukin-1 Agents in Kidney Transplant Recipients with Familial Mediterranean Fever and Amyloidosis: What have been learned so far?Baris Afsar, Rengin Elsurer Afsar, Yasar Caliskan, et al.
Transplantation Reviews (Orlando, Fla.)|June 23, 2024
Brain natriuretic peptide and N-terminal pro b-type natriuretic peptide in kidney transplantation: More than just cardiac markersBaris Afsar, Rengin Elsurer Afsar, Yasar Caliskan, et al.
International Urology and Nephrology|March 4, 2025
Sodium-glucose co-transporter inhibitors for APOL1 kidney disease: A call for studiesBaris Afsar, Rengin Elsurer Afsar, Yasar Caliskan, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|October 31, 2003
Major depression and psoriasis activation due to interferon-alpha in a patient with chronic myeloid leukemia; "overlooked and/or misdiagnosed adverse reaction in malignant disease"Sevgi Kalayoglu Besisik, Gönenc Kocabey, Yasar Caliskan
Current Opinion in Organ Transplantation|February 26, 2026
Genetic testing in living kidney donor candidatesYasar Caliskan, Laura Binari, Heidi M Schaefer
The International Journal of Artificial Organs|February 4, 2010
Outcomes of renal transplants from spousal donors: 25 years of experience at our centerNuman Gorgulu, Yasar Caliskan, Berna Yelken, et al.
Current Transplantation Reports|May 19, 2025
Complement-Mediated Kidney Disease and Living Donor Transplantation: Tailoring Approaches to Improve OutcomesAliza Anwar Memon, Krista L Lentine, Yasar Caliskan
Iranian Journal of Kidney Diseases|August 13, 2022
Silica Urinary Stones: A Case Report and A Brief Review of LiteratureYasar Caliskan, Jonathan Buck, Lindsay Lombardo, et al.
Transplantation|April 17, 2003
Cyclosporine-associated hyperkalemia: report of four allogeneic blood stem-cell transplant casesYasar Caliskan, Sevgi Kalayoglu-Besisik, Deniz Sargin, et al.
Seminars in Nephrology|July 22, 2025
Communicating Risk Alleles in Kidney Genes: Lessons from APOL1 and New Discoveries of Risk AllelesYasar Caliskan, Ana Iltis, Janewit Wongboonsin, et al.
Current Transplantation Reports|March 17, 2025
Use of Anti-interleukin-1 Agents in Kidney Transplant Recipients with Familial Mediterranean Fever and Amyloidosis: What have been learned so far?Baris Afsar, Rengin Elsurer Afsar, Yasar Caliskan, et al.
Transplantation Reviews (Orlando, Fla.)|June 23, 2024
Brain natriuretic peptide and N-terminal pro b-type natriuretic peptide in kidney transplantation: More than just cardiac markersBaris Afsar, Rengin Elsurer Afsar, Yasar Caliskan, et al.
International Urology and Nephrology|March 4, 2025
Sodium-glucose co-transporter inhibitors for APOL1 kidney disease: A call for studiesBaris Afsar, Rengin Elsurer Afsar, Yasar Caliskan, et al.
Pageof 15